OBJECTIVE: FSTL1 is a secreted glycoprotein that exacerbates murine arthritis and is overexpressed in human arthritis. The aim of this study was to determine the mechanism by which FSTL1 promotes arthritis. METHODS: Collagen-induced arthritis was induced in mice hypomorphic for FSTL1, generated with a gene trap-targeted mutant embryonic stem cell line. Arthritis was assessed by measuring paw swelling and using a qualitative arthritis index. Bone marrow-derived mesenchymal stromal cells from hypomorphic mice, as well as mouse stromal ST2 cells transduced with short hairpin RNA to suppress FSTL1 expression, were stimulated with interleukin-1β (IL-1β), tumor necrosis factor α, and IL-17. The monocyte cell line U937, which does not express FSTL1, was transfected with a plasmid encoding FSTL1 and stimulated with phorbol myristate acetate and lipopolysaccharide. Cell supernatants were assayed for IL-6, IL-8, monocyte chemotactic protein 1 (MCP-1), and FSTL1 by enzyme-linked immunosorbent assay. RESULTS: FSTL1 hypomorphic mice had reduced levels of FSTL1 compared to littermate controls. Following induction of arthritis, a significant correlation was observed between serum FSTL1 levels and both paw swelling and the arthritis index. Similar correlations were observed between the amount of FSTL1 produced by mesenchymal stromal cells, stromal ST2 cells, and monocytes and the secretion of IL-6, IL-8, and MCP-1. CONCLUSION: These findings demonstrate that FSTL1 up-regulates proinflammatory mediators important in the pathology of arthritis, and that serum levels of FSTL1 correlate with severity of arthritis. The latter supports the possibility that FSTL1 might be a target for treatment of certain forms of arthritis.
OBJECTIVE:FSTL1 is a secreted glycoprotein that exacerbates murinearthritis and is overexpressed in humanarthritis. The aim of this study was to determine the mechanism by which FSTL1 promotes arthritis. METHODS: Collagen-induced arthritis was induced in mice hypomorphic for FSTL1, generated with a gene trap-targeted mutant embryonic stem cell line. Arthritis was assessed by measuring paw swelling and using a qualitative arthritis index. Bone marrow-derived mesenchymal stromal cells from hypomorphic mice, as well as mouse stromal ST2 cells transduced with short hairpin RNA to suppress FSTL1 expression, were stimulated with interleukin-1β (IL-1β), tumor necrosis factor α, and IL-17. The monocyte cell line U937, which does not express FSTL1, was transfected with a plasmid encoding FSTL1 and stimulated with phorbol myristate acetate and lipopolysaccharide. Cell supernatants were assayed for IL-6, IL-8, monocyte chemotactic protein 1 (MCP-1), and FSTL1 by enzyme-linked immunosorbent assay. RESULTS:FSTL1 hypomorphic mice had reduced levels of FSTL1 compared to littermate controls. Following induction of arthritis, a significant correlation was observed between serum FSTL1 levels and both paw swelling and the arthritis index. Similar correlations were observed between the amount of FSTL1 produced by mesenchymal stromal cells, stromal ST2 cells, and monocytes and the secretion of IL-6, IL-8, and MCP-1. CONCLUSION: These findings demonstrate that FSTL1 up-regulates proinflammatory mediators important in the pathology of arthritis, and that serum levels of FSTL1 correlate with severity of arthritis. The latter supports the possibility that FSTL1 might be a target for treatment of certain forms of arthritis.
Authors: Peter A Nigrovic; Melissa Mannion; Femke H M Prince; Andrew Zeft; C Egla Rabinovich; Marion A J van Rossum; Elisabetta Cortis; Manuela Pardeo; Paivi M Miettunen; Ginger Janow; James Birmingham; Aaron Eggebeen; Erin Janssen; Andrew I Shulman; Mary Beth Son; Sandy Hong; Karla Jones; Norman T Ilowite; Randy Q Cron; Gloria C Higgins Journal: Arthritis Rheum Date: 2011-02
Authors: I M Johnston; H J Spence; J N Winnie; L McGarry; J K Vass; L Meagher; G Stapleton; B W Ozanne Journal: Oncogene Date: 2000-11-09 Impact factor: 9.867
Authors: Z Yao; W C Fanslow; M F Seldin; A M Rousseau; S L Painter; M R Comeau; J I Cohen; M K Spriggs Journal: Immunity Date: 1995-12 Impact factor: 31.745
Authors: Alexandra Peister; Jason A Mellad; Benjamin L Larson; Brett M Hall; Laura F Gibson; Darwin J Prockop Journal: Blood Date: 2003-10-30 Impact factor: 22.113
Authors: F Fossiez; O Djossou; P Chomarat; L Flores-Romo; S Ait-Yahia; C Maat; J J Pin; P Garrone; E Garcia; S Saeland; D Blanchard; C Gaillard; B Das Mahapatra; E Rouvier; P Golstein; J Banchereau; S Lebecque Journal: J Exp Med Date: 1996-06-01 Impact factor: 14.307
Authors: Brian T Campfield; Christi L Nolder; Anthony Marinov; Daniel Bushnell; Amy Davis; Caressa Spychala; Raphael Hirsch; Andrew J Nowalk Journal: Microb Pathog Date: 2014-04-24 Impact factor: 3.738
Authors: Matthew Henkel; Justin A Dutta; Jessica Partyka; Taylor Eddens; Raphael Hirsch; Jay K Kolls; Brian T Campfield Journal: Infect Immun Date: 2020-12-15 Impact factor: 3.441
Authors: Marina Miller; Andrew Beppu; Peter Rosenthal; Alexa Pham; Sudipta Das; Maya Karta; Dae Jin Song; Christine Vuong; Taylor Doherty; Michael Croft; Bruce Zuraw; Xu Zhang; Xiang Gao; Seema Aceves; Fazila Chouiali; Qutayba Hamid; David H Broide Journal: J Immunol Date: 2015-09-09 Impact factor: 5.422
Authors: Mark Gorelik; Ndate Fall; Mekibib Altaye; Michael G Barnes; Susan D Thompson; Alexei A Grom; Raphael Hirsch Journal: J Rheumatol Date: 2013-05-15 Impact factor: 4.666
Authors: Yury Chaly; Yu Fu; Anthony Marinov; Bruce Hostager; Wei Yan; Brian Campfield; John A Kellum; Daniel Bushnell; Yudong Wang; Jerry Vockley; Raphael Hirsch Journal: Eur J Immunol Date: 2014-02-20 Impact factor: 5.532